Navigation Links
Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA

The U.S. Food and Drug Administration has cleared DizzyFIX, an at-home treatment for vertigo and dizziness which helps guide patients through the Epley maneuver, for sale in the U.S.

Calgary, Canada (PRWEB) September 23, 2008 -- The U.S. Food and Drug Administration has cleared DizzyFIX, an at-home [treatment for vertigo] and dizziness which helps guide patients through the Epley maneuver, for sale in the U.S.

"DizzyFIX will now be available by prescription in the U.S. and is already available over-the-counter in Canada and other countries," said Dr. Alp Sener, MD, PhD. "Benign Paroxysmal Positional Vertigo (BPPV) is one of the leading causes of dizziness. Dizziness from BPPV affects as many as 10 per cent of people over age 60."

The FDA ruling followed an extensive review by the U.S. agency of peer-reviewed research demonstrating the effectiveness of the DizzyFIX in [treatment of BPPV].

Developed by ear, nose and throat specialists, the DizzyFIX is a low-cost, patent-pending dynamic visual-feedback device that easily attaches to a hat. It is used as a guide to the [Epley maneuvers] (particle repositioning maneuvers) that treat the most common cause of vertigo, BPPV.

As many as one in ten people over the age of 60 will suffer from the sudden spinning attacks that characterize BPPV, which can cause nausea, falls and long-term disability.

"Patients who suffer from vertigo now have an alternative to simply masking the symptoms with drug therapy," says Dr. Matthew Bromwich, DizzyFIX inventor and ear, nose and throat specialist. "DizzyFIX enables patients to treat and cure their own symptoms from the comfort of their own home."

The Makers of DizzyFIX
Clearwater Clinical Limited is an innovative Canadian company whose partners met during their education and are either in training or have recently completed training as specialist physicians and surgeons, clinical and basic scientists, computer specialists and businessmen.

Their primary objective is to foster the development of novel concepts in medical technology and introduce them into the marketplace. The team is geographically diverse and teleconferences from six cities in three countries.

To learn more about the DizzyFIX, please visit or see our site for background information on DizzyFIX and more information about the Epley Maneuver.

Dr. Jacob Jaremko
Clearwater Clinical Limited, makers of the DizzyFIX

# # #

Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
3. New Canadian study finds drug coated heart stents to be safe:
4. Canadians welcome HPV vaccine -- but not at any price
5. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
6. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
7. Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM)
8. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
9. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
10. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
11. Leading Travel Insurance Website Now Offers Mexican Auto Insurance to US and Canadian Travelers Going into Mexico
Post Your Comments:
Related Image:
Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA 
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: